Adverse reactions to this drug were reported in 74 (1.76%) of 4,208 patients evaluated before approval and during drug use-results surveys. The major adverse reactions included eyelid itching in 19 patients (0.45%), eye irritation in 15 patients (0.36%), conjunctival injection in 10 patients (0.24%) and blepharitis in 7 patients (0.17%) (at the end of the reexamination period).
If any adverse reactions are observed, appropriate measures such as discontinuing administration should be taken. (See Table 5.)
Click on icon to see table/diagram/image